Biofrontera (BFRI) Operating Income Growth (3y) (2023 - 2025)
Biofrontera (BFRI) Operating Income Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 40.17% |
| 10 | Biofrontera | 10.88 Mn | 4.47 Mn | 14.09 Mn | 41.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.23% |
| Sep 30, 2025 | -19.94% |
| Jun 30, 2025 | 6.49% |
| Mar 31, 2025 | -13.50% |
| Dec 31, 2024 | 3.43% |
| Sep 30, 2024 | 32.47% |
| Jun 30, 2024 | -11.21% |
| Mar 31, 2024 | -16.03% |
| Dec 31, 2023 | -173.95% |
| Sep 30, 2023 | -25.38% |